Synthesis of 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives as potential antimicrobial agents

被引:44
作者
Rameshkumar, N [1 ]
Ashokkumar, M [1 ]
Subramanian, EH [1 ]
Ilavarasan, R [1 ]
Sridhar, SK [1 ]
机构
[1] CL Baid Metha Coll Pharm, Dept Pharmaceut Chem & Pharmacol, Madras 600096, Tamil Nadu, India
关键词
fluoroquinolone; antibacterial; antifungal;
D O I
10.1016/S0223-5234(03)00151-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present study, a series of 1-ethyl/benzyl-6-fluoro-7-(substituted piperazin-1-yl)1,4-dihydro-4-oxo-quinoline-3-carboxylic acid were synthesized and characterized by IR, H-1-NMR, mass spectral and elemental analysis. The in vitro antibacterial and antifungal activities of the compounds were evaluated by paper disc diffusion method. The minimum inhibitory concentrations (MIC) of the compounds were also determined by agar streak dilution method. The in vivo antibacterial activity of the compounds against Escherichia coli was also evaluated by mouse protection test. All the compounds exhibited significant antibacterial and weak antifungal activities. The in vivo antibacterial activity (ED50) against E. coli was 50-160 mg kg(-1) in the order of 7 < 9 < 8 < 10. 1-Ethyl-6-fluoro-7-(2,5-dioxo-piperazin-1-yl)1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (7) was found to exhibit the most potent in vitro antimicrobial activity with MIC of 4.1, 3.1, 3.1, 2.4, 1, 1 25 and > 100 mug mL(-1) against Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus luteus, Bacillus cereus, E. coli, Klebsiella pneumoniae, Candida albicans and Aspergillus niger. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 17 条
[1]  
AHAD PGA, 1982, EUR J MED CHEM, V17, P301
[2]  
CARBATEAS PM, 1984, J HETEROCYCLIC CHEM, V21, P1857
[3]   SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF 1-ARYL-6,8-DIFLUOROQUINOLONE ANTIBACTERIAL AGENTS [J].
CHU, DTW ;
FERNANDES, PB ;
MALECZKA, RE ;
NORDEEN, CW ;
PERNET, AG .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) :504-509
[4]   SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS OF NOVEL ARYLFLUOROQUINOLONE ANTIBACTERIAL AGENTS [J].
CHU, DTW ;
FERNANDES, PB ;
CLAIBORNE, AK ;
PIHULEAC, E ;
NORDEEN, CW ;
MALECZKA, RE ;
PERNET, AG .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (11) :1558-1564
[5]   NEW STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE QUINOLONE ANTIBACTERIALS USING THE TARGET ENZYME - THE DEVELOPMENT AND APPLICATION OF A DNA GYRASE ASSAY [J].
DOMAGALA, JM ;
HANNA, LD ;
HEIFETZ, CL ;
HUTT, MP ;
MICH, TF ;
SANCHEZ, JP ;
SOLOMON, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) :394-404
[6]   1-ETHYL-7-[3-[(ETHYLAMINO)METHYL]-1-PYRROLIDINYL]-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINE-CARBOXYLIC ACID - A NEW QUINOLONE ANTIBACTERIAL WITH POTENT GRAM-POSITIVE ACTIVITY [J].
DOMAGALA, JM ;
HEIFETZ, CL ;
MICH, TF ;
NICHOLS, JB .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (04) :445-448
[7]  
Ecobichon DJ, 1977, BASIS TOXICOLOGY TES, P43
[8]   Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives [J].
Fang, KC ;
Chen, YL ;
Sheu, JY ;
Wang, TC ;
Tzeng, CC .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) :3809-3812
[9]  
Gillespie S.H., 1994, MED MICROBIOL ILLUS, P234, DOI DOI 10.1016/B978-0-7506-0187-0.50025-0
[10]  
GLUSHKOV RG, 1983, KHIM FARM ZH, V20, P313